All articles

Titration: What You Need To Know About Increasing Your GLP-1 Treatment Dosage

Titration: What You Need To Know About Increasing Your GLP-1 Treatment Dosage


Written by:

Dr. Zoë Lees (PhD)

Medically reviewed by:

Dr. Sophie Dix (BSc, PhD)

Published:

17 June 2025

Updated:

7 May 2026

Reading time: 8 minutes
Titration: What You Need To Know About Increasing Your GLP-1 Treatment Dosage

Article Summary:

  • Titration is the process of safely and gradually increasing your medication dose over time, while monitoring how your body responds.
  • GLP-1s (like Mounjaro and Wegovy) are hormone-based treatments. Titration is applied to their treatment, to help maximise their efficacy and minimise side effects.
  • In consultation with a healthcare professional, you can increase your dose once every 4 weeks as long as you're tolerating your dose and your side effects are manageable.

What is titration?

In medicine, titration is the process of safely and gradually increasing your medication dose over time. It's often used for medications which affect nerve or hormonal pathways, like metformin for type 2 diabetes and diuretics for high blood pressure. [1] [2] [3] And, as we'll learn, it's also used in certain types of weight loss treatments.

How does titration work?

Titration helps you find the best medication dosage for your needs. Ideally, this means balancing maximum effectiveness and minimising potential side effects, while giving your body the time it needs to adjust to your medication. [4]

Mounjaro dosage guide

Mounjaro dosage guide

Wegovy dosage guide

Wegovy dosage guide

Titration and weight loss injections

Weight loss injections like Mounjaro and Wegovy are hormone-based treatments. These Glucagon-like Peptide-Receptor Agonists (GLP-1s) work by acting just like your natural GLP-1 hormone, to regulate your appetite and increase satiety (feeling 'full'). [5] [6] This may help to minimise food cravings, prevent overeating and, over time, reduce your body weight. [5] [6]

GLP-1 medications, like Wegovy and Mounjaro, follow a structured titration schedule to ensure a smooth transition. However, dosing varies by medication:

Mounjaro

The starting dose for Mounjaro (tirzepatide) is 2.5 mg, taken once a week for four weeks. After 4 weeks, your dose may increase to 5 mg once a week. [5]

Your dose may increase by 2.5 mg increments, to 7.5 mg, 10 mg, 12.5 mg or 15 mg, taken once a week. This depends on how well you're tolerating the side effects of your dose. In each case, your healthcare provider will tell you to stay on a particular dose for at least 4 weeks before going to a higher dose. [5] For more information, please refer to your patient information leaflet or speak to your healthcare professional.

Learn more about how titration works when taking Mounjaro here:

▶️ Watch video

Wegovy

The starting dose for Wegovy (semaglutide) is 0.25 mg, taken once a week. [6] This dose is gradually increased every 4 weeks, over 16 weeks of treatment. You may be able to gradually increase your dose every 4 weeks until you reach the dose of 2.4 mg once weekly.

If you're living with obesity, you may be able to increase your dose to the maximum dose of 7.2 mg (3 injections of 2.4 mg), taken once weekly. This can be made after a minimum of 4 weeks on 2.4 mg. For more information, please refer to your patient information leaflet or speak to your healthcare provider. [6]

Learn more about how titration works when taking Wegovy here:

▶️ Watch video

Why do I start treatment on a lower dose?

Your treatment starts on a lower dose to help your body adjust to your new medication. It'll also help to minimise side effects. Increasing your dosage too quickly may make side effects worse. [7]

Digestive side effects are common when you start weight loss medication. When taking GLP-1 agonists, these most often include diarrhoea and nausea. [8] Fortunately, these side effects are often mild, and usually go away by the time you reach your maintenance dose. [9] However, there are also rarer, but more serious side effects to be aware of, like an allergic reaction. [5] [6]

For a full list of common and rare side effects, please refer to your patient information leaflet.

How frequently does titration happen when taking weight loss injections?

If you're taking a GLP-1 medication, you can increase your dose once every 4 weeks as long as you're tolerating your dose and your side effects are manageable.

At MedExpress, our team is here to guide you on dosage increases. We'll send you regular medicine reminders via email and, during each check-in, your practitioner will assess how you're responding to your medication, as well as the severity of any side effects. If they think you're ready to increase your dose, they'll let you know. Your increased dose will then be delivered with your next order.

You’ll continue increasing your dose every four weeks until you reach your maintenance dose.

What's a maintenance dose?

Your maintenance dose refers to the dose that provides the best results, while keeping side effects manageable. This may be the maximum recommended dose for your treatment, or it could be a lower dose that minimises any uncomfortable side effects you're experiencing. [10]

In short, it's the dose that feels right for you and your body.

How do I know if I'm ready to increase my dose?

You may want to increase your dose if:

  • Your weight loss has stayed the same for several weeks, despite lifestyle changes like a reduced calorie diet and increased physical activity.
  • 'Food noise' has returned, and you're increasingly noticing cravings, thinking about food all the time, or less feelings of fullness.
  • You're experiencing little to no side effects. If you've passed the 4-week adjustment period and your side effects have subsided, you may feel ready to increase your dose. Speak to your healthcare provider to check if this is possible. [11]

What if I want to switch weight loss treatments?

You may be able to switch from one form of weight loss medication to another as long as it's done with the approval of a health care professional. Some people decide to change due to side effects, or because one treatment’s more cost-effective than another.

But before you do switch, it might be worth exploring a lower dose of your current medication first. If you’re swapping from one type of weight loss injection to another because of side effects, you may still notice similar adverse reactions (like nausea and diarrhoea). This is because GLP-1 drugs like Mounjaro and Wegovy work in a similar way.

Whether you decide to switch or stay with your current medication, for best results keep your weekly injection schedule consistent. And, if you have any concerns about your progress, speak to your healthcare provider. They're there to support you during your weight loss and weight management journey.

Important information about titration

GLP-1 use must always be done with the approval of a certified healthcare professional. They’ll be able to monitor your progress and provide clinical guidance on unwanted reactions and side effects.

Be sure to read and follow the information provided in your patient information leaflet. This will arrive with each pen, and will also include detailed injection instructions.

And remember that any weight loss treatment works best alongside positive and sustainable lifestyle changes. These include a reduced calorie diet, increased physical activity and, ideally, 7-9 hours’ sleep a night. Having a weight management plan in place may help you maintain a healthy body weight beyond your treatment. [12]

Any questions?

MedExpress makes it simple and convenient to track your treatment progress. To complete a side effects consultation, visit your dashboard.

You'll also find our help centre, featuring our FAQs, here.

Find out which treatment may be suitable for you with MedExpress.

References

  1. Pope C. What does titration of a medicine mean? [Internet]. Drugs.com. 2024. Available from: https://www.drugs.com/medical-answers/titration-medication-3570939/
  2. NHS. Metformin [Internet]. NHS. 2019. Available from: https://www.nhs.uk/medicines/metformin/
  3. NHS. Pulmonary hypertension - Treatment [Internet]. nhs.uk. 2017. Available from: https://www.nhs.uk/conditions/pulmonary-hypertension/treatment/
  4. Caffrey AR, Borrelli EP. The art and science of drug titration. Therapeutic Advances in Drug Safety. 2020 Jan;11(11):204209862095891.
  5. Package leaflet: Information for the patient Mounjaro ® 2.5 mg KwikPen ® solution for injection in pre-filled pen Mounjaro ® 5 mg KwikPen ® solution for injection in pre-filled pen Mounjaro ® 7.5 mg KwikPen ® solution for injection in pre-filled pen Mounjaro ® 10 mg KwikPen ® solution for injection in pre-filled pen Mounjaro ® 12.5 mg KwikPen ® solution for injection in pre-filled pen Mounjaro ® 15 mg KwikPen ® solution for injection in pre [Internet]. Available from: https://www.medicines.org.uk/emc/files/pil.15481.pdf
  6. GB -Wegovy PIL-Version 7 [Internet]. Available from: https://www.medicines.org.uk/emc/files/pil.13799.pdf
  7. https://www.facebook.com/Drugscom. 6 Wegovy side effects you need to be aware of [Internet]. Drugs.com. Available from: https://www.drugs.com/medical-answers/6-wegovy-side-effects-you-aware-3573374/
  8. Wilding JPH, Batterham RL, Calanna S. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine [Internet]. 2021 Feb 10;384(11):989–1002. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  9. Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, Castro A, Cebrián-Cuenca A, de Torres-Sánchez A, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine [Internet]. 2023 Jan 1;12(1):145. Available from: https://www.mdpi.com/2077-0383/12/1/145
  10. Maddison JE, Page SW, Dyke TM. Clinical pharmacokinetics. Small Animal Clinical Pharmacology. 2008;27–40.
  11. Swearingen K. GLP-1 Dose Adjustments for Weight Loss [Internet]. Healthline. Healthline Media; 2026. Available from: https://www.healthline.com/health/drugs/glp-1-dose-adjustment-for-weight-loss#titration-schedules
  12. Contreras F, Al-Najim W, le Roux CW. Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes. Nutrients [Internet]. 2024 Oct 22;16(21):3585. Available from: https://www.mdpi.com/2072-6643/16/21/3585

Next scheduled review date: 7 May 2029

Authors

Dr. Zoë Lees, PhD Metabolic Medicine

Written by: Dr. Zoë Lees (PhD)

Dr. Zoë Lees is a medical writer at MedExpress specialising in obesity and health communication. She completed her PhD at the University of Glasgow, where she investigated adipose tissue (fat tissue) function in pregnancies complicated by pre-eclampsia and gestational diabetes. Her work focuses on translating complex clinical evidence into clear, engaging and evidence-based health information for patients and the public. At MedExpress, Zoë contributes to clinical content, educational resources and media communications across areas including weight management, GLP-1 therapies and metabolic disease. Zoë is particularly interested in improving public understanding of obesity as a chronic condition and ensuring patients have access to accurate, accessible health information grounded in current scientific evidence.

Dr. Sophie Dix

Medically reviewed by: Dr. Sophie Dix (BSc, PhD)

Dr. Sophie Dix is Head of Medical Affairs at MedExpress. A behavioural neuroscientist by training, Sophie has spent 30 years working at the intersection of medical research, pharmacology, technology and patient communication across the pharmaceutical industry, health technology and charity sectors. At MedExpress, Sophie's role is to ensure that everything the organisation does is grounded in the most current science. That means translating complex clinical evidence into accessible health information across the website, clinical pathways and media communications. It also means working with external press and broadcast media as a named expert commentator, making the science behind weight management and GLP-1 treatments understandable to a general audience. A core part of Sophie's work is building MedExpress's Real-World Evidence (RWE) programme: learning systematically from patient outcomes to understand what works in practice, not just in clinical trials. This patient-level insight feeds directly into improving patient experience and health outcomes. Sophie believes that patients make better decisions when they have access to accurate, evidence-based information. As an advocate for meaningful change in how obesity is understood, Sophie works to reduce stigma and raise awareness of the condition as an illness. This includes reframing the conversation around GLP-1s from aesthetics to public health, while highlighting the health benefits of weight loss and weight management.

Note from the experts

Remember: This blog shouldn’t be regarded as medical advice, diagnosis, or treatment. We make sure everything we publish is fact checked by clinical experts and regularly reviewed, but it may not always reflect the most recent health guidelines. Always speak to your doctor about any health concerns you have.